Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Lorenskog – page 5

69 clinical trials in Lorenskog, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Lorenskog at a glance
69
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

69 trials in Lorenskog

Open in trial search

Breast cancer

Not recruiting

Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Helse Bergen HF

Primary adrenal insufficiency

Not recruiting

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Cortisone
  • Sponsor:Helse Bergen HF

Idiopathic pulmonary fibrosis

Not recruiting

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:BI 1819479
  • Sponsor:Boehringer Ingelheim Espana S.A.

Interstitial lung disease

Not recruiting

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational
Countries:NorwayNorway
  • Participants:65+ years
  • Substances:BI 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

Plasma cell myeloma

Not recruiting

Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Oslo University Hospital HF

Pituitary tumour benign

Not recruiting

Study on Cabergoline for Treating Non-Functioning Pituitary Adenomas in Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Cabergoline
  • Sponsor:St. Olavs Hospital HF

K-ras gene mutation+2

Not recruiting

Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sotorasib
  • Sponsor:Vestre Viken HF

Colorectal cancer+6

Not recruiting

Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:INCB099280
  • Sponsor:Incyte Corp.

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Not recruiting
Investigational
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Transitional cell carcinoma

Not recruiting

Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Seagen Inc.

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Lorenskog

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on pancreatic ductal cancer, multiple myeloma, and advanced gastric cancers. Research includes innovative combination therapies and personalized treatment approaches.

  • Breast Cancer Treatment Optimization
  • Small-cell Lung Cancer Therapy
  • Prostate Cancer Biomarkers

Trials evaluating novel drug combinations and immunotherapy approaches for better patient outcomes.

02 Neurological Disorders

Clinical investigations examining treatments for Alzheimer's disease and multiple sclerosis. Studies focus on both pharmaceutical interventions and innovative therapeutic approaches.

  • Memory Loss Prevention
  • MS Treatment Enhancement
  • Cognitive Function Studies

Research emphasizes disease-modifying therapies and symptom management strategies.

03 Respiratory Medicine

Studies addressing COPD and severe asthma, including evaluation of new combination therapies and treatment protocols for respiratory conditions.

  • Viral Respiratory Infections
  • Asthma Management
  • Antibiotic Therapy Assessment

Focus on improving lung function and quality of life for patients with chronic respiratory conditions.

04 Gastrointestinal Research

Innovative trials examining treatments for Crohn's Disease and ulcerative colitis, with emphasis on combination therapies and novel therapeutic approaches.

  • Inflammatory Bowel Disease
  • Cholangitis Treatment
  • GI Cancer Therapies

Research aimed at improving disease management and patient outcomes.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.